Masayuki Munekane

Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At)

Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 32 citations

Medicinal Chemistry, Engineering, Radionuclide Therapy +12

RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics

Kenji Mishiro, Sayaka Imai, Yuki Ematsu et al. · Journal of Medicinal Chemistry · 2022 · 28 citations

Development of New Zinc Dithiosemicarbazone Complex for Use as Oral Antidiabetic Agent

Saori Kadowaki, Masayuki Munekane, Yoji Kitamura et al. · Biological Trace Element Research · 2013 · 19 citations

Biochemistry, Medicine, Diabetes +4

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 19 citations · Full text

Synthesis of an amphiphilic tetrazine derivative and its application as a liposomal component to accelerate release of encapsulated drugs

Kento Kannaka, Kohei Sano, Masayori Hagimori et al. · Bioorganic & Medicinal Chemistry · 2019 · 18 citations

Lipid Preparation, Medicinal Chemistry, Liposomal Component +7